{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:33:39Z","timestamp":1791275619902,"version":"4.1.0"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Purpose: Osteopontin (OPN) is an integrin-binding protein overexpressed in various experimental models of malignancy and appears to be involved in tumorigenesis and metastasis. Although various studies have assessed OPN protein levels in several tumor types, a broad survey of OPN expression in human neoplasia under the same experimental conditions has not been carried out.<\/jats:p>\n               <jats:p>Experimental Design: We used immunohistochemistry to detect OPN in a selection of 350 human tumors and 113 normal tissues, from a variety of body sites, using stage-oriented human cancer tissue arrays. Tumors included malignancies from breast (26), ovary (22), endometrium (14), esophagus (10), stomach (11), pancreas (16), bile duct (1), liver (9), colon (20), kidney (53), bladder (33), prostate (28), head and neck (60), salivary glands (14), lung (17), skin (6), and brain (10).<\/jats:p>\n               <jats:p>Results: High cytoplasmic OPN staining was observed in 100% of gastric carcinomas, 85% of colorectal carcinomas, 82% of transitional cell carcinomas of the renal pelvis, 81% of pancreatic carcinomas, 72% of renal cell carcinomas, 71% of lung and endometrial carcinomas, 70% of esophageal carcinomas, 58% of squamous cell carcinomas of the head and neck, and 59% of ovarian carcinomas. Although OPN expression was identified in a good number of bladder, prostate, and brain tumors, the majority of 6 skin cancers, 11 of 14 salivary gland cancers, 2 thyroid carcinomas, and 23 of 26 breast cancers revealed low OPN positivity or were negative. When considering all sites, OPN expression significantly correlated with tumor stage (Spearman\u2019s correlation coefficient, P = 0.0002). OPN score and stage were also significantly correlated for specific cancer sites including bladder (P = 0.01), colon (P = 0.004), kidney (P = 0.0001), larynx (P = 0.035), mouth (P = 0.046), and salivary gland (P = 0.011).<\/jats:p>\n               <jats:p>Conclusions: This study reports the broad distribution of OPN in human tumors from different body sites, suggesting involvement of this protein in tumor formation. The strong correlation between pathological stage and OPN across multiple tumor types suggests a role for OPN in tumor progression.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-1405-2","type":"journal-article","created":{"date-parts":[[2005,9,21]],"date-time":"2005-09-21T23:52:12Z","timestamp":1127346732000},"page":"184-190","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":267,"title":["Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor Histologies"],"prefix":"10.1158","volume":"10","author":[{"given":"Domenico","family":"Coppola","sequence":"first","affiliation":[{"name":"1Department of Pathology, University of South Florida College of Medicine, Tampa, Florida;2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Szabo","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of South Florida College of Medicine, Tampa, Florida;2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boulware","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Oncology, Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida;3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Muraca","sequence":"additional","affiliation":[{"name":"Clinomics BioSciences, Inc., Pittsfield, Massachusetts;4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Alsarraj","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Oncology, Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida;3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann F.","family":"Chambers","sequence":"additional","affiliation":[{"name":"London Regional Cancer Centre, London, Ontario, Ontario, Canada; and5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Yeatman","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of South Florida College of Medicine, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,1,20]]},"reference":[{"key":"2023011320412751300_B1","doi-asserted-by":"crossref","unstructured":"Sodek J., Ganss B., McKee M. D. Osteopontin. Crit. Rev. Oral Biol. Med., 11:\u2008279-303, \u20082000.","DOI":"10.1177\/10454411000110030101"},{"key":"2023011320412751300_B2","unstructured":"Tuck A. B., O\u2019Malley F. P., Singhal H., Tonkin K. S., Harris J. F., Bautista D., et al Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. Arch. Pathol. Lab. Med., 121:\u2008578-584, \u20081997."},{"key":"2023011320412751300_B3","doi-asserted-by":"crossref","unstructured":"Chambers A. F., Wilson S. M., Kerkvliet N., O\u2019Malley F. P., Harris J. F., Casson A. G. Osteopontin expression in lung cancers. Lung Cancer, 15:\u2008311-323, \u20081996.","DOI":"10.1016\/0169-5002(95)00595-1"},{"key":"2023011320412751300_B4","unstructured":"Thalmann G. N., Sikes R. A., Devoll R. E., Kiefer J. A., Markwalder R., Klima I., et al Osteopontin: possible role in prostate cancer progression. Clin. Cancer Res., 5:\u20082271-2277, \u20081999."},{"key":"2023011320412751300_B5","doi-asserted-by":"crossref","unstructured":"Agrawal D., Chen T., Irby R., Quackenbush J., Chambers A. F., Szabo M., Coppola D., Yeatman T. J. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J. Natl. Cancer Inst. (Bethesda), 94:\u2008513-521, \u20082002.","DOI":"10.1093\/jnci\/94.7.513"},{"key":"2023011320412751300_B6","doi-asserted-by":"crossref","unstructured":"Tuck A. B., Chambers A. F. The role of osteopontin in breast cancer: clinical and experimental studies. J. Mamm. Gland Biol. Neoplasia, 6:\u2008419-429, \u20082001.","DOI":"10.1023\/A:1014734930781"},{"key":"2023011320412751300_B7","doi-asserted-by":"crossref","unstructured":"Furger K. A., Menon R. K., Tuck A. B., Bramwell V. H., Chambers A. F. The functional and clinical roles of osteopontin in cancer and metastasis. Curr. Mol. Med., 1:\u2008621-632, \u20082001.","DOI":"10.2174\/1566524013363339"},{"key":"2023011320412751300_B8","unstructured":"Oates A. J., Barraclough R., Rudland P. S. The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis, 17:\u20081-15, \u20081997."},{"key":"2023011320412751300_B9","doi-asserted-by":"crossref","unstructured":"Reinholt F. P., Hultenby K., Oldberg A., Heinegard D. Osteopontin: a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA, 87:\u20084473-4475, \u20081990.","DOI":"10.1073\/pnas.87.12.4473"},{"key":"2023011320412751300_B10","doi-asserted-by":"crossref","unstructured":"Giachelli C. M., Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol., 19:\u2008615-622, \u20082000.","DOI":"10.1016\/S0945-053X(00)00108-6"},{"key":"2023011320412751300_B11","doi-asserted-by":"crossref","unstructured":"Staal A., vanWijnen A. J., Birkenhager J. C., Pols H. A. P., Prahl J., DeLuca H., Gaub M-P., Lian J. B., Stein G. S., van Leeuwen J. P. T. M., Stein J. L. Distinct conformations of vitamin D receptor\/retinoid X receptor-\u03b1 heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol. Endocrinol., 10:\u20081444-1456, \u20081996.","DOI":"10.1210\/mend.10.11.8923469"},{"key":"2023011320412751300_B12","doi-asserted-by":"crossref","unstructured":"Senger D. R., Asch B. B., Smith B. D., Perruzzi C. A., Dvorak H. F. A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature (Lond.), 302:\u2008714-715, \u20081983.","DOI":"10.1038\/302714a0"},{"key":"2023011320412751300_B13","unstructured":"Senger D. R., Perruzzi C. A., Papadopoulos A. Elevated expression of secreted phosphoprotein I (osteopontin 2ar) as a consequence of neoplastic transformation. Anticancer Res., 9:\u20081291-1300, \u20081989."},{"key":"2023011320412751300_B14","doi-asserted-by":"crossref","unstructured":"Craig A. M., Nemir M., Mukherjee B. B., Chambers A. F., Denhardt D. T. Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar\/osteopontin: enhanced expression in H-ras-transformed 3T3 cells. Biochem. Biophys. Res. Commun., 157:\u2008166-173, \u20081988.","DOI":"10.1016\/S0006-291X(88)80028-7"},{"key":"2023011320412751300_B15","doi-asserted-by":"crossref","unstructured":"Craig A. M., Bowden G. T., Chambers A. F., Spearman M. A., Greenberg A. H., Wright J. A., McLeod M., Denhardt D. T. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int. J. Cancer, 46:\u2008133-137, \u20081990.","DOI":"10.1002\/ijc.2910460124"},{"key":"2023011320412751300_B16","unstructured":"Chambers A. F., Behrend E. I., Wilson S. M., Denhardt D. T. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res., 12:\u200843-48, \u20081992."},{"key":"2023011320412751300_B17","unstructured":"Oates A. J., Barraclough R., Rudland P. S. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene, 13:\u200897-104, \u20081996."},{"key":"2023011320412751300_B18","unstructured":"Patarca R., Saavedra R. A., Cantor H. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1\/osteopontin gene. Crit. Rev. Immunol., 13:\u2008225-246, \u20081993."},{"key":"2023011320412751300_B19","unstructured":"Shijubo N., Uede T., Kon S., Nagata M., Abe S. Vascular endothelial growth factor and osteopontin in tumor biology. Crit. Rev. Oncog., 11:\u2008135-146, \u20082000."},{"key":"2023011320412751300_B20","unstructured":"Senger D. R., Peruzzi C. A., Gracey C. F., Papadopoulos A., Tenen D. G. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res., 48:\u20085770-5774, \u20081988."},{"key":"2023011320412751300_B21","doi-asserted-by":"crossref","unstructured":"Bautista D. S., Saad Z., Chambers A. F., Tonkin K. S., O\u2019Malley F. P., Singhal H., Tokmakejian S., Bramwell V., Harris J. F. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women. Clin. Biochem., 29:\u2008231-239, \u20081996.","DOI":"10.1016\/0009-9120(96)84728-A"},{"key":"2023011320412751300_B22","unstructured":"Singhal H., Bautista D. S., Tonkin K. S., O\u2019Malley F. P., Tuck A. B., Chambers A. F., Harris J. F. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin. Cancer Res., 3:\u2008605-611, \u20081997."},{"key":"2023011320412751300_B23","unstructured":"Fedarko N. S., Jain A., Karadag A., Van Eman M. R., Fisher L. W. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin. Cancer Res., 7:\u20084060-4066, \u20082001."},{"key":"2023011320412751300_B24","doi-asserted-by":"crossref","unstructured":"Hotte S. J., Winquist E. W., Stitt L., Wilson S. M., Chambers A. F. Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer (Phila.), 95:\u2008506-512, \u20082002.","DOI":"10.1002\/cncr.10709"},{"key":"2023011320412751300_B25","doi-asserted-by":"crossref","unstructured":"Kim J. H., Skates S. J., Uede T., Wong K. k. K. K., Schorge J. O., Feltmate C. M., Berkowitz R. S., Cramer D. W., Mok S. C. Osteopontin as a potential diagnostic biomarker for ovarian cancer. J. Am. Med. Assoc., 287:\u20081671-1679, \u20082002.","DOI":"10.1001\/jama.287.13.1671"},{"key":"2023011320412751300_B26","doi-asserted-by":"crossref","unstructured":"Tuck A. B., O\u2019Malley F. P., Singhal H., Harris J. F., Tonkin K. S., Kerkvliet N., Saad Z., Doig G. S., Chambers A. F. Osteopontin expression in a group of lymph node negative breast cancer patients. Int. J. Cancer Predict. Oncol., 79:\u2008502-508, \u20081998.","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3"},{"key":"2023011320412751300_B27","unstructured":"Senger D. R., Ledbetter S. R., Claffey K. P., Papadopoulos-Sergiou A., Perruzzi C. A., Detmar M. Stimulation of endothelial cell migration by vascular permeability factor\/vascular endothelial growth factor through cooperative mechanisms involving the \u03b1\u03bd\u03b23 integrin, osteopontin, and thrombin. Am. J. Pathol., 149:\u2008293-305, \u20081996."},{"key":"2023011320412751300_B28","doi-asserted-by":"crossref","unstructured":"Liaw L., Skinner M. P., Raines E. W., Ross R., Cheresh D. A., Schwartz S. M., Giachelli C. M. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J. Clin. Investig., 95:\u2008713-724, \u20081995.","DOI":"10.1172\/JCI117718"},{"key":"2023011320412751300_B29","doi-asserted-by":"crossref","unstructured":"Hu D. D., Lin E. C. K., Kovach N. L., Hoyer J. R., Smith J. W. A biochemical characterization of the binding of osteopontin to integrins \u03b1v\u03b21 and \u03b1v\u03b25. J. Biol. Chem., 270:\u200826232-26238, \u20081995.","DOI":"10.1074\/jbc.270.44.26232"},{"key":"2023011320412751300_B30","doi-asserted-by":"crossref","unstructured":"Weber G. F., Ashkar S., Glimcher M. J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (\u03b7-1). Science (Wash. DC), 271:\u2008509-512, \u20081996.","DOI":"10.1126\/science.271.5248.509"},{"key":"2023011320412751300_B31","unstructured":"Katagiri Y. U., Sleeman J., Fujii H., Herrlich P., Hotta H., Tanaka K., Chikuma S., Yagita H., Okomura K., Murakami M., Saiki I., Chambers A. F., Uede T. CD44 variants but not CD44s cooperate with \u03b21-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res., 59:\u2008219-226, \u20081999."},{"key":"2023011320412751300_B32","doi-asserted-by":"crossref","unstructured":"Xuan J. W., Hota C., Shigeyama Y., D\u2019Errico J. A., Somerman M. J., Chambers A. F. Site-directed mutagenesis of the arginin-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. J. Cell. Biochem., 57:\u2008680-690, \u20081995.","DOI":"10.1002\/jcb.240570413"},{"key":"2023011320412751300_B33","doi-asserted-by":"crossref","unstructured":"Bautista D. S., Xuan J., Hota C., Chambers A. F., Harris J. F. Inhibition of Arg-Gly-Asp (RGD) mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. J. Biol. Chem., 269:\u200823280-23285, \u20081994.","DOI":"10.1016\/S0021-9258(17)31650-2"},{"key":"2023011320412751300_B34","doi-asserted-by":"crossref","unstructured":"Tuck A. B., Elliott B. E., Hota C., Tremblay E., Chambers A. F. Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J. Cell. Biochem., 78:\u2008465-475, \u20082000.","DOI":"10.1002\/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C"},{"key":"2023011320412751300_B35","doi-asserted-by":"crossref","unstructured":"Brown L. F., Berse B., Van de Water L., Papadopoulos-Sergiou A., Perruzzi C. A., Manseau E. J., Dvorak H. F., Senger D. R. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell, 3:\u20081169-1180, \u20081992.","DOI":"10.1091\/mbc.3.10.1169"},{"key":"2023011320412751300_B36","unstructured":"Brown L. F., Papadopoulos-Sergiou A., Berse B., Manseau E. J., Tognazzi K., Peruzzi C. A., Dvorak H. F., Senger D. R. Osteopontin expression and distribution in human carcinomas. Am. J. Pathol., 145:\u2008610-623, \u20081994."},{"key":"2023011320412751300_B37","doi-asserted-by":"crossref","unstructured":"Allred D. C., Clark G. M., Elledge R., Fuqua S. A. W., Brown R. W., Chamness G. C., Osborne C. K., McGuire W. L. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl. Cancer Inst. (Bethesda), 85:\u2008200-206, \u20081993.","DOI":"10.1093\/jnci\/85.3.200"},{"key":"2023011320412751300_B38","doi-asserted-by":"crossref","unstructured":"Maki M., Hirota S., Kaneko Y., Morohoshi T. Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: a possible association with calcification of psammoma bodies. Pathol. Int., 50:\u2008531-535, \u20082000.","DOI":"10.1046\/j.1440-1827.2000.01075.x"},{"key":"2023011320412751300_B39","doi-asserted-by":"crossref","unstructured":"Singh R. P., Patarca R., Schwartz J., Singh P., Kantor H. Definition of a specific interaction between early T lymphocyte activation 1 (\u03b7-1) protein and murine macrophages in vitro and its effects upon macrophages in vivo. J. Exp. Med., 171:\u20081931-1942, \u20081990.","DOI":"10.1084\/jem.171.6.1931"},{"key":"2023011320412751300_B40","doi-asserted-by":"crossref","unstructured":"Behrend E. I., Craig A. M., Wilson S. M., Denhardt D. T., Chambers A. F. Expression of antisense osteopontin RNA in metastatic mouse fibroblasts is associated with reduced malignancy. Ann. N. Y. Acad. Sci., 760:\u2008299-301, \u20081995.","DOI":"10.1111\/j.1749-6632.1995.tb44640.x"},{"key":"2023011320412751300_B41","doi-asserted-by":"crossref","unstructured":"Li G., Chen Y. F., Kelpke S. S., Oparil S., Thompson J. A. Estrogen attenuates integrin-\u03b23-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells. Circulation, 101:\u20082949-2955, \u20082000.","DOI":"10.1161\/01.CIR.101.25.2949"},{"key":"2023011320412751300_B42","doi-asserted-by":"crossref","unstructured":"Spencer T. E., Bazer F. W. Biology of progesterone action during pregnancy recognition and maintenance of pregnancy. Front. Biosci., 7:\u2008d1879-d1898, \u20082002.","DOI":"10.2741\/A886"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/10\/1\/184\/1951418\/zdf00104000184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/10\/1\/184\/1951418\/zdf00104000184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T21:19:20Z","timestamp":1673644760000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/10\/1\/184\/165489\/Correlation-of-Osteopontin-Protein-Expression-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,1,20]]},"published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-1405-2","relation":{},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}